These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28182331)

  • 41. Can Mapping Algorithms Based on Raw Scores Overestimate QALYs Gained by Treatment? A Comparison of Mappings Between the Roland-Morris Disability Questionnaire and the EQ-5D-3L Based on Raw and Differenced Score Data.
    Madan J; Khan KA; Petrou S; Lamb SE
    Pharmacoeconomics; 2017 May; 35(5):549-559. PubMed ID: 28063083
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patient-reported chronic rhinosinusitis disease control is a valid measure of disease burden.
    Phillips KM; Houssein FA; Singerman K; Boeckermann LM; Sedaghat AR
    Rhinology; 2021 Dec; 59(6):545-551. PubMed ID: 34762075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mapping the FACT-B Instrument to EQ-5D-3L in Patients with Breast Cancer Using Adjusted Limited Dependent Variable Mixture Models versus Response Mapping.
    Gray LA; Wailoo AJ; Hernandez Alava M
    Value Health; 2018 Dec; 21(12):1399-1405. PubMed ID: 30502783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets.
    van Hout B; Janssen MF; Feng YS; Kohlmann T; Busschbach J; Golicki D; Lloyd A; Scalone L; Kind P; Pickard AS
    Value Health; 2012; 15(5):708-15. PubMed ID: 22867780
    [TBL] [Abstract][Full Text] [Related]  

  • 45. EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasis.
    Pickard AS; Gooderham M; Hartz S; Nicolay C
    J Med Econ; 2017 Jan; 20(1):19-27. PubMed ID: 27471948
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interim EQ-5D-5L Value Set for Poland: First Crosswalk Value Set in Central and Eastern Europe.
    Golicki D; Niewada M; Hout BV; Janssen MF; Pickard AS
    Value Health Reg Issues; 2014 Sep; 4():19-23. PubMed ID: 29702801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mapping the Beck Depression Inventory to the EQ-5D-3L in Patients with Depressive Disorders.
    Grochtdreis T; Brettschneider C; Hajek A; Schierz K; Hoyer J; Koenig HH
    J Ment Health Policy Econ; 2016 Jun; 19(2):79-89. PubMed ID: 27453455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mapping EORTC-QLQ-C30 to EQ-5D-3L in patients with colorectal cancer.
    Marriott ER; van Hazel G; Gibbs P; Hatswell AJ
    J Med Econ; 2017 Feb; 20(2):193-199. PubMed ID: 27676291
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Can EQ-5D-3L utility values of low back pain patients be validly predicted by the Oswestry Disability Index for use in cost-effectiveness analyses?
    Pellekooren S; Ben ÂJ; Bosmans JE; Ostelo RWJG; van Tulder MW; Maas ET; Huygen FJPM; Oosterhuis T; Apeldoorn AT; van Hooff ML; van Dongen JM
    Qual Life Res; 2022 Jul; 31(7):2153-2165. PubMed ID: 35040002
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A; Green C; Telford C; Zajicek J; Wright D
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Responsiveness and minimal clinically important difference for the EQ-5D in chronic rhinosinusitis.
    Hoehle LP; Phillips KM; Speth MM; Caradonna DS; Gray ST; Sedaghat AR
    Rhinology; 2019 Apr; 57(2):110-116. PubMed ID: 30175337
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determinants of noticeable symptom improvement despite sub-MCID change in SNOT-22 score after treatment for chronic rhinosinusitis.
    Phillips KM; Hoehle LP; Caradonna DS; Gray ST; Sedaghat AR
    Int Forum Allergy Rhinol; 2019 May; 9(5):508-513. PubMed ID: 30597742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chinese adaptation and validation of the chronic rhinosinusitis-patient-reported outcome: Assessment of health-related quality-of-life.
    Chen J; Hu L; Zhang C; Shi L; Zhang Q; Zhou Y; Cheng F; Gao Y; Li H; Wang D; Wang H; Sun X
    Int Forum Allergy Rhinol; 2024 May; 14(5):950-960. PubMed ID: 37823234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantifying the Relationship between Capability and Health in Older People: Can't Map, Won't Map.
    Franklin M; Payne K; Elliott RA
    Med Decis Making; 2018 Jan; 38(1):79-94. PubMed ID: 29056069
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patient-reported outcome measures for adult chronic rhinosinusitis: A systematic review and quality assessment.
    Rudmik L; Hopkins C; Peters A; Smith TL; Schlosser RJ; Soler ZM
    J Allergy Clin Immunol; 2015 Dec; 136(6):1532-1540.e2. PubMed ID: 26654198
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of postoperative endoscopy upon clinical outcomes after endoscopic sinus surgery.
    Schlosser RJ; Storck K; Smith TL; Mace JC; Rudmik L; Shahangian A; Soler ZM
    Int Forum Allergy Rhinol; 2016 Feb; 6(2):115-23. PubMed ID: 26458330
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chinese time trade-off values for EQ-5D health states.
    Liu GG; Wu H; Li M; Gao C; Luo N
    Value Health; 2014 Jul; 17(5):597-604. PubMed ID: 25128053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Obtaining EQ-5D-3L utility index from the health status scale of traditional Chinese medicine (TCM-HSS) based on a mapping study.
    Wang L; Lu Y; Dai Z; Shi P; Xu J; Chang F; Lu Y
    Health Qual Life Outcomes; 2022 Dec; 20(1):164. PubMed ID: 36522665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low 22-item sinonasal outcome test scores in chronic rhinosinusitis: Why do patients seek treatment?
    Levy JM; Mace JC; Rudmik L; Soler ZM; Smith TL
    Laryngoscope; 2017 Jan; 127(1):22-28. PubMed ID: 27377575
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differences in the Sino-Nasal Outcome Test 22 and visual analog scale symptom scores in chronic rhinosinusitis with and without nasal polyps.
    Gregurić T; Trkulja V; Baudoin T; Grgić M; Šmigovec I; Kalogjera L
    Am J Rhinol Allergy; 2016; 30(2):107-12. PubMed ID: 26980391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.